Cargando…
Reassessing the Potential of Myb-targeted Anti-cancer Therapy
Transcription factor MYB is essential for the tumorigenesis of multiple cancers, especially leukemia, breast cancer, colon cancer, adenoid cystic carcinoma and brain cancer. Thus, MYB has been regarded as an attractive target for tumor therapy. However, pioneer studies of antisense oligodeoxynucleot...
Autores principales: | Liu, Xiaofeng, Xu, Yunxiao, Han, Liping, Yi, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907674/ https://www.ncbi.nlm.nih.gov/pubmed/29675107 http://dx.doi.org/10.7150/jca.23992 |
Ejemplares similares
-
Reassessing target antigens for adoptive T cell therapy
por: Hinrichs, Christian S., et al.
Publicado: (2013) -
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer
por: Cicirò, Ylenia, et al.
Publicado: (2021) -
The MYB transcription factor CiMYB42 regulates limonoids biosynthesis in citrus
por: Zhang, Pan, et al.
Publicado: (2020) -
Reassessing the Reassessment of suPAR in Glomerular Disease
por: Meijers, Björn K. I., et al.
Publicado: (2015) -
Is It Time to Reassess the Role of Radiotherapy Treatment in Ovarian Cancer?
por: Macchia, Gabriella, et al.
Publicado: (2023)